Synthesis and molecular modeling study of Cu(II) complexes derived from 2-(diphenylmethylene)hydrazinecarbothioamide derivatives with cholinesterase inhibitory activities

Chinese Chemical Letters

Volumn 24, Issue 7, 2013, Pages 609-612

  Chan, Yi Chen ^a   Mohamed Ali, Abdussalam Salhin ^a   Khairuddean, Melati ^a   Khaw, Kooi Yeong ^b   Murugaiyah, Vikneswaran ^b   Basiri, Alireza ^b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Cholinesterase; Molecular modeling; Thiosemicarbazone Cu(II) complex

Indexed keywords

EID: 84879056822     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2013.04.013     Document Type: Article

References (17)

1. G. Small, and R. Bullock Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease Alzheimers Dement. 7 2011 177 184
2. M.A. Kamal, P. Klein, and Q.S. Yu Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine J. Alzheimers Dis. 10 2006 43 51
3. H.J. Han, J.J. Lee, and S.A. Park Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease J. Clin. Neurol. 7 2011 137 142
4. A. Adsersen, A. Kjølbye, and O. Dall Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava schweigg. & kort J. Ethnopharmacol. 113 2007 179 182
5. N.H. Greig, D.K. Lahiri, and K. Sambamurti Butyrylcholinesterase: an important new target in Alzheimer's disease therapy Int. Psychogeriatr. 14 2002 77 91
6. A. Fallarero, P. Oinonen, and S. Gupta Inhibition of acetylcholinesterase by coumarins: the case of coumarin 106 Pharmacol. Res. 58 2008 215 221
7. Z. Yang, X. Zhang, and D. Duan Modified TLC bioautographic method for screening acetylcholinesterase inhibitors from plant extracts J. Sep. Sci. 32 2009 3257 3259
8. P.K. Mukherjee, V. Kumar, and M. Mal Acetylcholinesterase inhibitors from plants Phytomedicine 14 2007 289 300
9. A. Budimir, N. Humbert, and M. Elhabiri Hydroxyquinoline based binders: promising ligands for chelatotherapy? J. Inorg. Biochem. 105 2011 490 496
10. D.J. Bonda, G. Liu, and P. Men Nanoparticle delivery of transition-metal chelators to the brain: oxidative stress will never see it coming CNS Neurol. Disord. Drug Targets 11 2012 81 85
11. M. Ikram, R. Saeed Ur, and S. Rehman Synthesis, characterization and distinct butyrylcholinesterase activities of transition metal complexes of 2-[(E)-(quinolin-3-ylimino)methyl]phenol Inorg. Chim. Acta 390 2012 210 216
12. M.C. Rodriguez-Argüelles, M.B. Ferrari, and G.G. Fava Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity J. Inorg. Biochem. 66 1997 7 17
13. S. Sharma, F. Athar, and M.R. Maurya Novel bidentate complexes of Cu(II) derived from 5-nitrofuran-2-carboxaldehyde thiosemicarbazones with antiamoebic activity against E. histolytica Eur. J. Med. Chem. 40 2005 557 562
14. G. Vatsa, O.P. Pandey, and S.K. Sengupta Synthesis, spectroscopic and toxicity studies of titanocene chelates of isatin-3-thiosemicarbazones Bioinorg. Chem. Appl. 3 2005 151 160
15. G.L. Ellman, D. Courtney, and V.J. Andres A new and rapid colorimetric determination of acetylcholinesterase activity BioChem. Pharmacol. 7 1961 88 95
16. A. Zawadzka, I. Łozińska, and Z. Molȩda Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers J. Pineal Res. 2012
17. S.M. Salga, H.M. Ali, and M.A. Abdullah Synthesis, characterization, acetylcholinesterase inhibition, molecular modeling and antioxidant activities of some novel Schiff bases derived from 1-(2-ketoiminoethyl)piperazines Molecules 16 2011 9316 9330